Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Dermatology|December 2, 2019
Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational StudyAndrea Chiricozzi, Martina Burlando, Giacomo Caldarola, et al.
Italian Journal of Dermatology and Venereology|December 6, 2019
Ingenol mebutate therapy in erythroplasia of Queyrat: a new approachIlaria Proietti, Simone Michelini, Nevena Skroza, et al.
Cancers|October 2, 2020
Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic ReviewIlaria Proietti, Nevena Skroza, Nicoletta Bernardini, et al.
Journal of Personalized Medicine|December 27, 2024
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective StudyNicoletta Bernardini, Annunziata Dattola, Raimondo Rossi, et al.
Cancers|July 11, 2020
BRAF Inhibitors: Molecular Targeting and Immunomodulatory ActionsIlaria Proietti, Nevena Skroza, Simone Michelini, et al.
Dermatology and Therapy|May 10, 2024
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian SettingSarah Alulis, Nicoletta Bernardini, Martina Burlando, et al.
Clinical and Experimental Dermatology|June 27, 2025
Predictive Factors of Eczematous Eruptions and Candidiasis during anti IL-17 Treatment in Psoriatic Patients: a Multicenter Italian Real-life Experience in Lazio RegionGiacomo Caldarola, Eleonora De Luca, Simone Amato, et al.
Dermatologic Therapy|March 20, 2022
Adverse skin reactions to personal protective equipment during COVID-19 pandemic in Italian health care workersIlaria Proietti, Ivan Borrelli, Nevena Skroza, et al.
Clinics and Practice|July 27, 2026
Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio RegionGiuseppe P A Gemma, Nicoletta Bernardini, Francesca Paola Sasso, et al.
Drugs in Context|September 12, 2024
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVENicoletta Bernardini, Nevena Skroza, Laura Atzori, et al.
Pageof 9